Healthcare - Biotechnology - NASDAQ - US
$ 2.89
-16.2 %
$ 237 M
Market Cap
-1.62
P/E
Price Target
Average
315.22%
Revenue Forecast
Estimate
21.38%
EBIT
Estimate
--32.65%
Net Income
Estimate
13.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sutro Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for STRO of $12 , with forecasts ranging from a low of $8 to a high of $18 .
STRO Lowest Price Target
Wall Street Target
8 USD
176.82%
STRO Average Price Target
Wall Street Target
12 USD
315.22%
STRO Highest Price Target
Wall Street Target
18 USD
522.84%
REVENUE FORECAST
Revenue Forecast Chart STRO
EBIT FORECAST
EBIT Forecast Chart STRO
NET INCOME FORECAST
Net Income Chart STRO